로딩 중…
지수 로딩 중…
Aprogen Biologics Inc.
003060· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩2,110-6.84%
2026-06-19
Price Chart
Aprogen Biologics Inc.+219.21%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 30.41B KRW |
| Revenue | 78.00B KRW |
| Net Income | -131.89B KRW |
| Total Assets | 576.99B KRW |
| Net Assets | 272.85B KRW |
| Employees | 427 |
| Value | |
| P/B | 0.11x |
| P/S | 0.39x |
| FCF Yield | -157.37% |
| Profitability | |
| ROE | -48.34% |
| ROA | -22.86% |
| Op. Margin | -74.66% |
| Revenue Growth | 28.33% |
| Financial Health | |
| Debt Ratio | 211.47% |
| Total Debt | 332.48B KRW |
| FCF | -47.86B KRW |
| Cash | 23.76B KRW |
| Current Ratio | 0.67x |
| Performance | |
| 1Y Return | 219.21% |
| 1M Return | -34.27% |
| From 52W High | -66.88% |
| 1Y MDD | -69.87% |
| Trading | |
| Volume | 115,250 shares |
| Foreign Own. | 2.41% |
| Per Share | |
| EPS | -9,919 KRW |
| BPS | 16,437 KRW |
Company Info
Aprogen Biologics, founded in 1960, absorbed an affiliate with biopharmaceutical production facilities and technology in 2022, and also incorporated N2TEC, a semiconductor equipment component manufacturer and seller, as a subsidiary. The company's core businesses include pharmaceutical and bio divisions focused on medicine manufacturing and sales, as well as semiconductor equipment component production. Its Osong factory boasts the world's fifth-largest antibody production capacity and collaborates with Aprogen on the production and commercialization of biosimilar medicines. Aprogen Biologics is headquartered in Songpa-gu, Seoul.